Carbocisteine 5% syrup for adults

Quốc gia: Armenia

Ngôn ngữ: Tiếng Anh

Nguồn: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Thành phần hoạt chất:

carbocisteine

Sẵn có từ:

Arpimed LLC

INN (Tên quốc tế):

carbocisteine

Liều dùng:

250mg/5ml

Dạng dược phẩm:

syrup

Loại thuốc theo toa:

OTC

Đặc tính sản phẩm

                                SUMMARY PRODUCT CHARACTERISTIC (SPC)
CARBOCISTEINE 5 % SYRUP FOR ADULTS
TRADE NAME– Carbocisteine 5 % syrup for adults
INTERNATIONAL NON-PROPERTY NAME– Carbocisteine
COMPOSITION
Each 5 ml of Carbocisteine 5% syrup for adults contains:
_ACTIVEINGREDIENT:_
carbocisteine-250 mg;
_INACTIVE INGREDIENTS:_ sodium saccharin, propylene glycol, _
_sucrose,methylparaben,
aroma
caramel, sodium hydroxide, color yellow E 110,water deionized ._ _
CHEMICAL NAME AND CAS NUMBER
(2R)-2-amino-3-[(carboxymethyl)sulphanyl]propanoic acid
,
2387-59-9.
PHARMACOLOGICAL GROUP AND ATC CODE
Mucolytic agent. ATC code
R05CB03.
PHARMACOLOGICAL ACTION
_Pharmacodynamic properties _
Carbocisteine (S-carboxymethyl L-cysteine) has been shown in normal
and bronchitic animal
models to affect the nature and amount of mucus glycoprotein which is
secreted by the
respiratory
tract.
An
increase
in
the
acid:neutral
glycoprotein
ratio
of
the
mucus
and
a
transformation of serous cells to mucus cells is known to be the
initial response to irritation and
will normally be followed by hypersecretion. The administration of
Carbocisteine to animals
exposed
to
irritants
indicates
that
the
glycoprotein
that
is
secreted
remains
normal;
administration after exposure indicates that return to the normal
state is accelerated. Studies in
humans have demonstrated that Carbocisteine reduces goblet cell
hyperplasia. Carbocisteine can
therefore be demonstrated to have a role in the management of
disorders characterised by
abnormal mucus.
_Pharmacokinetic properties _
Carbocisteineis rapidly absorbed from the gastrointestinal tract, peak
plasma concentrations are
reached after about hour(рН 7-9). Bioavailability is low, less than
10% ,probably, due to the
metabolism in the gastrointestinal tract and "first pass" through the
liver.
Carbocisteine is excreted primarily by the kidneys. The half-life is
about 2 hours.
USES
Violations of bronchial secretions (including acute bronchitis and
acute exacerbations of chronic
diseases of the bronchi and lungs).
DOSAGEANDADMINISTRATIO
                                
                                Đọc toàn bộ tài liệu
                                
                            

Tài liệu bằng các ngôn ngữ khác

Tờ rơi thông tin Tờ rơi thông tin Tiếng Nga 27-08-2014

Tìm kiếm thông báo liên quan đến sản phẩm này